Sulfasalazine

CAS No. 599-79-1

Sulfasalazine( Azopyrin | NSC 203730 | NSC 667219 )

Catalog No. M15233 CAS No. 599-79-1

Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G 48 In Stock

Biological Information

  • Product Name
    Sulfasalazine
  • Note
    Research use only, not for human use.
  • Brief Description
    Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent.
  • Description
    Sulfasalazine, a sulfa agent and a derivative of mesalazine, is used primarily as an anti-inflammatory agent. Target: Others Sulfasalazine (Azulfidine), used to treat pain and swelling in arthritis, belongs to a class of drugs called sulfa drugs.(In Vitro):Treatment of SW620 colon cells with sulfasalazine inhibits TNFα-, LPS-, or phorbol ester-induced NFκB activation. NFκB-dependent transcription is inhibited by sulfasalazine at micro- to millimolar concentrations. TNFα-induced nuclear translocation of NFκB is prevented by sulfasalazine through inhibition of IκBα degradation. Pre-incubation with 5 mM of sulfasalazine alone significantly increases basal mRNA expression of all pro-inflammatory cytokines with levels of IL-6 mRNA increased by 80-fold compared with vehicle control. Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity.(In Vivo):At low doses (0.25 mM), SAS is able to suppress glioma growth by over 60% compared to untreated controls.
  • In Vitro
    Treatment of SW620 colon cells with sulfasalazine inhibits TNFα-, LPS-, or phorbol ester-induced NFκB activation. NFκB-dependent transcription is inhibited by sulfasalazine at micro- to millimolar concentrations. TNFα-induced nuclear translocation of NFκB is prevented by sulfasalazine through inhibition of IκBα degradation. Pre-incubation with 5 mM of sulfasalazine alone significantly increases basal mRNA expression of all pro-inflammatory cytokines with levels of IL-6 mRNA increased by 80-fold compared with vehicle control. Once digested, sulfasalazine is cleaved into sulfapyridine and 5-aminosalicylic acid by colonic bacteria, and the latter, too, is reported to suppress NF-kappaB activity.
  • In Vivo
    At low doses (0.25 mM), SAS is able to suppress glioma growth by over 60% compared to untreated controls.
  • Synonyms
    Azopyrin | NSC 203730 | NSC 667219
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-1| COX-2| NF-κB
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    599-79-1
  • Formula Weight
    398.39
  • Molecular Formula
    C18H14N4O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 80 mg/mL (200.8 mM)
  • SMILES
    O=C(O)C1=CC(/N=N/C2=CC=C(S(=O)(NC3=NC=CC=C3)=O)C=C2)=CC=C1O
  • Chemical Name
    (E)-2-hydroxy-5-((4-(N-(pyridin-2-yl)sulfamoyl)phenyl)diazenyl)benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Weber CK, et al. Gastroenterology. 2000 Nov;119(5):1209-18.
molnova catalog
related products
  • Etodolac

    A nonsteroidal anti-inflammatory drug that acts as a non-selective inhibitor of COX with IC50 of 53.5 nM.

  • Lvguidingan

    Lvguidingan is an Anticonvulsant agent.

  • Indobufen

    Indobufen is an inhibitor of platelet aggregation and is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes.